Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease'. Together they form a unique fingerprint.

Medicine & Life Sciences